DeutschNewstral
Article
Mmarketwatch.com on 2015-11-09 22:49
Mallinckrodt’s stock tumbles as short seller Citron claims next victim
Related news
- MLigand Pharma stock tanks after short seller Citron calls it 'pipe dream'marketwatch.com
- MIGC stock rockets, but pares some gains after short-seller Citron takes aimmarketwatch.com
Prominent short-seller Citron targets Coinbase stock after exchange outagecointelegraph.com- MWayfair's stock sinks after short seller Citron takes aimmarketwatch.com
Andrew Left’s Citron Will Stop
Publishing Short-Seller Reportswsj.com- MCronos stock tumbles after Citron makes short call, sets $3.50 price targetmarketwatch.com
- MShort seller Citron ‘scratching our heads’ at Mobileye’s buyout by Intelmarketwatch.com
- MPeloton shares could be headed to $5, short-seller Citron Research saysmarketwatch.com
- MShort-seller Citron 'scratching our heads' at Mobileye buyout but is moving onmarketwatch.com
Citron Research’s Andrew Left: Meet the short seller behind those negative reports on Valeant Pharmaceuticals Incbusiness.financialpost.com- MUPDATE: Exact Sciences Corp. stock drops 3% after short-seller Citron Research targets its colon cancer testmarketwatch.com
- MSpanish blood plasma company stock tumbles after short-seller research report2 min readmarketwatch.com
- MMeet the short seller who rocked Valeant’s stock this weekmarketwatch.com
- BShort-Seller Citron Research Says to Buy Netflix Shares. Really.barrons.com
- MTransDigm extends recent losses after short seller Citron weighs inmarketwatch.com
- MTesla shares rocket 5% as short seller Citron reverses positionmarketwatch.com
Short seller Citron switches to long position on Tesla sharesNew York Post- FShort seller sets sights on Mallinckrodtft.com
- MAxon stock at risk of losing half its value, short seller Spruce Point saysmarketwatch.com
- BFacebook Stock Rises as Short Seller Andrew Left Decides It’s a Buybarrons.com